北大医院的研究.pdfVIP

Journal of Clinical Virology 75 (2016) 10–15 Contents lists available at ScienceDirect Journal of Clinical Virology j o u r n a l h o m e p ag e: w w w. elsev /locate/jcv Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus Yao Chen a , Lan-Ping Xu a , Kai-Yan Liu a , Huan Chen a , Yu-Hong Chen a , Xiao-Hui Zhang a , Yu Wang a , Feng-Rong Wang a , Wei Han a , Jing-Zhi Wang a , Chen-Hua Yan a , Xiao-Jun Huang a,b,∗ a Peking University People’s Hospital, Peking University Institute of Hematology, PR China b Peking-Tsinghua Centerfor Life Sciences, PR China a r t i c l e i n f o a b s t r a c t Article history: Background: The risk factors associated with CMV DNAemia are not well known after haploidentical stem Received 29 June 2015 cell transplantation (SCT). Received in revised form Objectives: This study investigated the risk factors and prognosis for CMV DNAemia among CMV sero- 10 November 2015 matched donors and recipients (D+/R+). Accepted 10 December 2015 Study design: A retrospective study of patients undergoing haploidentical stem cell transplantation (SCT) between January 2010 and January 2012 was conducted. Cox regression analysis was performed Keywords: to identify the risk factors for CMV DNAemia. These possible factors included recipient/donor age, Cytomegalovirus (CMV) Hepatitis B virus (